Pharmanutra S.p.A. (FRA:761)

Market Cap	761.23M +68.1%
Revenue (ttm)	132.16M +13.8%
Net Income	20.00M +20.4%
EPS	2.09 +20.6%
Shares Out	n/a
PE Ratio	38.06
Forward PE	31.07
Dividend	1.00 (1.26%)
Ex-Dividend Date	May 5, 2025

Volume	n/a
Average Volume	5
Open	79.40
Previous Close	80.60
Day's Range	79.40 - 79.40
52-Week Range	38.55 - 84.00
Beta	n/a
RSI	58.37
Earnings Date	May 14, 2026

About Pharmanutra

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for mu...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 128
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 761

Financial Performance

In 2025, Pharmanutra's revenue was 132.16 million, an increase of 13.78% compared to the previous year's 116.15 million. Earnings were 20.00 million, an increase of 20.44%.